DOSTINEX

Medicinal product

(Invented) name

DOSTINEX

Active substance (s)

Kabergolinas

Strength

500 µg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G02CB03, Cabergoline

Marketing authorisation holder

Pfizer Italia S.r.l., Italija

Date of authorisation

2001-10-08

Date of renewal

2009-07-21

Documents

1619_1-3_DOSTINEX_tab_RPP_210122.docx

1619_1-3_Pakuotes lapelis_210122.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Kabergolinas	500 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
3184	8683	1008683	buteliukas	N2		Receptinis	LT/1/01/1619/001	Netiekiama	-	-	No	-	-
3185	8684	1008684	buteliukas	N4		Receptinis	LT/1/01/1619/002	Netiekiama	-	-	No	-	-
3186	8685	1008685	buteliukas	N8		Receptinis	LT/1/01/1619/003	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-06-30	Išregistruotas
2009-07-21	Perregistruotas
2001-10-08	Registruotas